Evox Therapeutics picks up $95.4m Series C

Evox Therapeutics Ltd, an exosome therapeutics company, has raised $95.4 million in a Series C financing.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this